Stay updated on Venetoclax Regimen to Prevent AML Relapse Clinical Trial

Sign up to get notified when there's something new on the Venetoclax Regimen to Prevent AML Relapse Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax Regimen to Prevent AML Relapse Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    3%
    Check dated 2025-06-20T18:17:30.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.2 to v2.16.3.
    Difference
    0.3%
    Check dated 2025-06-13T15:58:29.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.3%
    Check dated 2025-06-06T09:36:14.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    5%
    Check dated 2025-05-30T04:34:49.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.9%
    Check dated 2025-05-23T01:51:33.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-05-01T06:10:19.000Z thumbnail image

Stay in the know with updates to Venetoclax Regimen to Prevent AML Relapse Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax Regimen to Prevent AML Relapse Clinical Trial page.